期刊文献+

生物制剂在狼疮肾炎治疗中的应用

下载PDF
导出
摘要 一、狼疮肾炎治疗的演变和局限 系统性红斑狼疮(systemic lupus erythematosus,SLE)是自身免疫介导的,以免疫性炎症为突出表现的弥漫性结缔组织病。血清抗核抗体为代表的多种自身抗体阳性和多系统受累是SLE的主要临床特征。
作者 胡章学
出处 《临床肾脏病杂志》 2015年第5期260-263,共4页 Journal Of Clinical Nephrology
  • 相关文献

参考文献21

  • 1CameronJS. Lupus nephritis: an historical perspective 1968- 1998[J].J Nephrol , 1999, 12 Suppl2: S29-41.
  • 2CAMERONJS. Lupus Nephritis[J].J Am Soc Nephrol , 1999, 10(2): 413-424.
  • 3GregersenJW,Jayne DR B-cell depletion in the treatment of lupusnephritis[J]. Nat Rev Nephrol, 2012, 8(9): 505-514.
  • 4Lewis EJ, Hunsicker LG, Lan Sp, et al. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group[J]. N EnglJ Med, 1992, 326(21): 1373-1379.
  • 5Euler HH, SchroederJO, Zeuner RA, et al. A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: design of the LPSG trial[J]. IntJ Artif Or?gans, 1991, 14(10): 639-646.
  • 6Rovin BH, Parikh SV. Lupus nephritis: the evolving role of novel therapeuticsj I]. AmJ Kidney Dis, 2014, 63 (4): 677- 690.
  • 7Clatworthy MR,Smith KG. B cells in glomerulonephritis: fo?cus on lupus nephritis[J]. Semin Irnmunopathol , 2007, 29 (4): 337-353.
  • 8Rovin BH, Furie R, Latinis K, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study[J]. Arthritis Rheum, 2012, 64(4): 1215-1226.
  • 9MerrillJT, Neuwelt CM, Wallace DJ, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase III III systemic lupus erythematosus evaluation of rituximab trial[J]. Arthritis Rheum, 2010, 62(1): 222-233.
  • 10Weidenbusch M,Rommele C, Schrottle A, et al. Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephri?tis[J]. Nephrol Dial Transplant, 2013, 28(1): 106-111.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部